Disrupted routines, school closures, increased stress, and less physical activity and proper nutrition all likely contributed to rises in childhood obesity rates during the pandemic.
Research presented at a recent Food and Drug Administration (FDA) workshop indicates the need for more comprehensive testing of new medications in people with obesity.
On January 9th, the American Academy of Pediatrics published new clinical practice guidelines for evaluating and treating obesity in children and adolescents.